Stock A373110 XCELL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Xcell Therapeutics Inc.

Equities

A373110

KR7373110006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-07-14 EDT 		5-day change 1st Jan Change
8,330 KRW -16.70% Intraday chart for Xcell Therapeutics Inc. 0.00% 0.00%
10:59am Xcell Therapeutics Shares Fall 4.7% Below Offering Price on Kosdaq Debut MT
07-08 Xcell Therapeutics Inc. has completed an IPO in the amount of KRW 16.18 billion. CI

Business Summary

XCell Therapeutics Inc is a Korea-based company mainly engaged in the development and manufacture of cell culture medium. The Company mainly conducts research, development and production of cell culture media, a material for biopharmaceuticals.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,830,212 8,506,049 ( 78.54 %) 0 78.54 %

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
XCELL THERAPEUTICS INC. Stock Xcell Therapeutics Inc.
0.00% 64.98M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+63.33% 856B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+39.34% 631B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.04% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.82% 325B
ABBVIE INC. Stock AbbVie Inc.
+8.98% 297B
ROCHE HOLDING AG Stock Roche Holding AG
+5.73% 234B
NOVARTIS AG Stock Novartis AG
+16.67% 226B
AMGEN INC. Stock Amgen Inc.
+15.85% 177B
PFIZER, INC. Stock Pfizer, Inc.
+2.15% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A373110 Stock
  4. Company Xcell Therapeutics Inc.